Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nitric Oxide - Noxy Health Product

Next Previous
Drug Profile

Nitric Oxide - Noxy Health Product

Alternative Names: Advanox; NOX-1416

Latest Information Update: 15 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator NOxy Health Products
  • Class Anti-infectives; Anti-inflammatories; Antiacnes; Antiandrogens; Antibacterials; Antibronchitics; Antifibrotics; Antifungals; Antihypertensives; Antineoplastics; Antituberculars; Antivirals; Cardiovascular therapies; Diagnostic agents; Foot disorder therapies; Free radicals; Nitrogen oxides; Non-opioid analgesics; Skin disorder therapies; Small molecules; Vascular disorder therapies; Vasodilators
  • Mechanism of Action Inflammation mediator modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Diabetic foot ulcer

Most Recent Events

  • 25 Mar 2025 Phase-I clinical trials in Diabetic foot ulcer (Adjunctive treatment) in USA (Topical) (NCT06402565)
  • 09 May 2024 NOxy Health Products plans a phase I trial for Diabetic foot ulcer in November 2024 (Topical, Foam) (NCT06402565)
  • 16 Jan 2024 NOxy Health Products suspendes phase I trial in Diabetic foot ulcer in Israel (Topical) because of enrollment disruptions due to the current situation in Israel, and concerns over the placebo batch stability results (NCT06020664)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top